Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma
Withdrawn before enrolling · Phase 2
Conditions studied: Melanoma, Malignant Melanoma
In brief
The purpose of this study is to determine whether an outpatient combination of lovastatin and low-to-moderate dose interferon is effective in the treatment of patients with malignant melanoma.
Key facts
- Study ID
- NCT00963664
- Run by
- NeoPlas Innovation
- People needed
- 250
- Starts
- 2009-12-01
- Expected to finish
- 2016-12-01
- Last updated by the study team
- 2009-09-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- NeoPlas Innovation — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.